Iroven 500 mg Injection

About Iroven 500 mg Injection

The injection Iroven 500 mg contains Ferric Carboxymaltose and is made by Orion Pharma Ltd. It is not a general tonic and should not be used without a confirmed need for iron replacement.

There are 15 brands of Ferric Carboxymaltose listed in Bangladesh. The lowest listed price is Ferium Injection 500 mg/10 ml at ৳ 700 per unit.

What is Iroven 500 mg Injection?

Made by Orion Pharma Ltd., Iroven 500 mg is a injection whose active ingredient is Ferric Carboxymaltose. It belongs to a group of medicines called parenteral iron preparations. It is given by a healthcare professional, not by the patient at home. Whether it suits you is a decision for your doctor.

Uses of Iroven 500 mg

It is not a general tonic and should not be used without a confirmed need for iron replacement. The iron in the injection helps replace the body's iron stores. Iroven 500 mg is used to treat iron deficiency anaemia in adults who have intolerance to oral iron or an unsatisfactory response to oral iron, and in adults with non-dialysis dependent chronic kidney disease. Ask your doctor whether it is right for your condition.

How to use Iroven 500 mg

Iroven 500 mg is given by a healthcare professional as an intravenous injection or infusion. Do not inject it yourself unless a doctor has shown you how. Take Iroven 500 mg 500 mg/10 ml injection exactly as your doctor prescribes. The doctor decides the dose, the number of doses and the course, taking into account the patient's weight and condition. The doctor decides the dose and course, including how the doses are spaced and whether treatment is repeated.

Side effects of Iroven 500 mg

Some people may experience nausea, vomiting, headache, dizziness, flushing, changes in taste, constipation, itching, rash, hives, wheezing, injection site discolouration, or changes in blood pressure. Seek urgent medical help if you develop breathing difficulty, swelling, severe dizziness, or collapse after receiving it. Serious allergic-type reactions can occur, which is why it is given where such reactions can be managed. Tell your doctor if any side effect bothers you or does not go away. Ask your doctor about any side effect that worries you.

Safety and precautions

Serious hypersensitivity reactions can occur, so monitoring during and after administration is needed, and it should only be given where staff and treatments for such reactions are immediately available. Do not receive it if you are allergic to any of its components. It is pregnancy category C, so ask your doctor whether it is suitable if you are pregnant, planning pregnancy, or breastfeeding. Keep out of reach of children.

Frequently asked questions

Why is Iroven 500 mg prescribed?

It is not a general tonic and should not be used without a confirmed need for iron replacement. The iron in the injection helps replace the body's iron stores.

How should I take Iroven 500 mg?

Iroven 500 mg is given by a healthcare professional as an intravenous injection or infusion. Do not inject it yourself unless a doctor has shown you how.

Can Iroven 500 mg cause side effects?

Some people may experience nausea, vomiting, headache, dizziness, flushing, changes in taste, constipation, itching, rash, hives, wheezing, injection site discolouration, or changes in blood pressure. Seek urgent medical help if you develop breathing difficulty, swelling, severe dizziness, or collapse after receiving it.

Can I use Iroven 500 mg in pregnancy or while breastfeeding?

Serious hypersensitivity reactions can occur, so monitoring during and after administration is needed, and it should only be given where staff and treatments for such reactions are immediately available. Do not receive it if you are allergic to any of its components.

Indications

Ferric Carboxymaltose is indicated for the treatment of iron deficiency anemia in adult patients-
  • Who have intolerance to oral iron or have had unsatisfactory response to oral iron
  • Who have non-dialysis dependent chronic kidney disease.

Pharmacology

Non-dextran, IV is a colloidal iron hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron; replaces iron stores found in hemoglobin, myoglobin, and enzymes; works to transport oxygen via hemoglobin Macrophage engulf FCM from blood and control iron release. Transferrin saturates and, Iron into the liver, spleen and Bone marrow.

Dosage & Administration

For patients weighing 50 kg or more: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 750 mg for a total cumulative dose not to exceed 1500 mg of iron per course.

For patients weighing less than 50 kg: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 15 mg/kg body weight for a total cumulative dose not to exceed 1500 mg of iron per course.

The dosage of Ferric Carboxymaltose is expressed in mg of elemental iron. Each mL of Ferric Carboxymaltose contains 50 mg of elemental iron. Ferric Carboxymaltose treatment may be repeated if iron deficiency anemia reoccurs.

Administer Ferric Carboxymaltose intravenously, either as an undiluted slow intravenous push or by infusion. When administering as a slow intravenous push, give at the rate of approximately 100 mg (2 mL) per minute. When administered via infusion, dilute up to 750 mg of iron in no more than 250 mL of sterile 0.9% sodium chloride injection, USP, such that the concentration of the infusion is not less than 2 mg of iron per mL and administer over at least 15 minutes.

When added to an infusion bag containing 0.9% Sodium Chloride Injection, USP, at concentrations ranging from 2 mg to 4 mg of iron per mL, Ferric Carboxymaltose solution is physically and chemically stable for 72 hours when stored at room temperature. To maintain stability, do not dilute to concentrations less than 2 mg iron/mL.

Inspect parenteral drug products visually for the absence of particulate matter and discoloration prior to administration. The product contains no preservatives. Each vial of Ferric Carboxymaltose is intended for single use only. Any unused drug remaining after injection must be discarded.

Avoid extravasation of Ferric Carboxymaltose since brown discoloration of the extravasation site may be long lasting. Monitor for extravasation. If extravasation occurs, discontinue the Ferric Carboxymaltose administration at that site.

Interaction

There are no known drug interactions and none well documented.

Contraindications

Hypersensitivity to any of its components.

Side Effects

Nausea, Hypertension, Flushing, Decreased blood phosphorus, Dizziness, Vomiting, Pruritus, Rash, Urticaria, Wheezing, Injection site discoloration, Headache, Increased alanine aminotransferase), Dysgeusia, Hypotension, Constipation, Serious anaphylactic/anaphylactoid reactions

Pregnancy & Lactation

Pregnancy Category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Precautions & Warnings

Hypersensitivity Reactions: Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Ferric carboxymaltose. Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse. Monitor patients for signs and symptoms of hypersensitivity during and after Ferric carboxymaltose administration for at least 30 minutes and until clinically stable following completion of the infusion. Only administer Ferric carboxymaltose when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions. Other serious or severe adverse reactions potentially associated with hypersensitivity which included, but not limited to, pruritus, rash, urticaria, wheezing, or hypotension may occur.

Hypertension: 
Transient elevations in systolic blood pressure, sometimes occurring with facial flushing, dizziness, or nausea were observed. These elevations generally occurred immediately after dosing and resolved within 30 minutes. Monitor patients for signs and symptoms of hypertension following each Ferric carboxymaltose administration.

Storage Conditions

Do not store above 30°C. Do not freeze.

Alternative brands of Ferric Carboxymaltose

Other brands with the same generic name, cheapest first.

See all 15 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.